$HLTHQ
Cue Health Inc. Stock $hlthq

$hlthq Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162894522000052 Filed on May 11, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$179.4M	$64.50M
YoY Change	178.16%
Cost Of Revenue	$86.70M
YoY Change
Gross Profit	$92.71M
YoY Change
Gross Profit Margin	51.68%
Selling, General & Admin	$61.08M	$12.30M
YoY Change	396.57%
% of Gross Profit	65.88%
Research & Development	$28.79M	$7.409M
YoY Change	288.54%
% of Gross Profit	31.05%
Depreciation & Amortization	$10.61M	$4.884M
YoY Change	117.16%
% of Gross Profit	11.44%
Operating Expenses	$89.87M	$19.71M
YoY Change	355.96%
Operating Profit	$2.848M	$14.76M
YoY Change	-80.7%
Interest Expense	-$51.00K	-$535.0K
YoY Change	-90.47%
% of Operating Profit	-1.79%	-3.63%
Other Income/Expense, Net	$6.000K	$37.00K
YoY Change	-83.78%
Pretax Income	$2.803M	$14.26M
YoY Change	-80.34%
Income Tax	$0.00	$1.226M
% Of Pretax Income	0.0%	8.6%
Net Earnings	$2.803M	$13.03M
YoY Change	-78.49%
Net Earnings / Revenue	1.56%	20.2%
Basic Earnings Per Share	$0.02	$0.09
Diluted Earnings Per Share	$0.02	$0.08
COMMON SHARES
Basic Shares Outstanding	146.5M shares	18.38M shares
Diluted Shares Outstanding	153.0M shares	25.90M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$426.5M
YoY Change
Cash & Equivalents	$426.5M	$38.94M
Short-Term Investments
Other Short-Term Assets	$9.807M
YoY Change
Inventory	$132.6M
Prepaid Expenses	$42.90M
Receivables	$75.83M
Other Receivables	$0.00
Total Short-Term Assets	$701.4M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$267.0M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.679M
YoY Change
Total Long-Term Assets	$282.4M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$701.4M
Total Long-Term Assets	$282.4M
Total Assets	$983.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.84M
YoY Change
Accrued Expenses	$47.40M
YoY Change
Deferred Revenue	$84.63M
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$2.620M
YoY Change
Total Short-Term Liabilities	$191.7M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$2.627M
YoY Change
Other Long-Term Liabilities	$6.356M
YoY Change
Total Long-Term Liabilities	$6.356M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$191.7M
Total Long-Term Liabilities	$6.356M
Total Liabilities	$258.6M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$21.22M
YoY Change
Common Stock	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$725.1M	-$85.27M
YoY Change
Total Liabilities & Shareholders Equity	$983.8M
YoY Change

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$2.803M	$13.03M
YoY Change	-78.49%
Depreciation, Depletion And Amortization	$10.61M	$4.884M
YoY Change	117.16%
Cash From Operating Activities	$31.52M	-$35.11M
YoY Change	-189.77%
INVESTING ACTIVITIES
Capital Expenditures	$12.78M	$30.49M
YoY Change	-58.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$14.06M	-$31.84M
YoY Change	-55.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00	$24.48M
YoY Change	-100.0%
Cash From Financing Activities	-$873.0K	$56.64M
YoY Change	-101.54%
NET CHANGE
Cash From Operating Activities	$31.52M	-$35.11M
Cash From Investing Activities	-$14.06M	-$31.84M
Cash From Financing Activities	-$873.0K	$56.64M
Net Change In Cash	$16.59M	-$10.31M
YoY Change	-260.89%
FREE CASH FLOW
Cash From Operating Activities	$31.52M	-$35.11M
Capital Expenditures	$12.78M	$30.49M
Free Cash Flow	$18.74M	-$65.60M
YoY Change	-128.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001628945
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40590
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Cue Health Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1562193
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4980 Carroll Canyon Rd.
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
CY2022Q1	dei	City Area Code CityAreaCode	858
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	412-8151
CY2021Q4	us-gaap	Assets Assets	940060000	USD
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	HLTH
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	147453254	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426465000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	409873000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	13838000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	13837000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75830000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	104589000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	39809000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	37208000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45889000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	9807000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7446000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	132567000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	88388000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	42902000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	701409000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	670022000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	182750000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	177456000	USD
CY2022Q1	hlth	Prepaid Rent Noncurrent PrepaidRentNoncurrent	480000	USD
CY2021Q4	hlth	Prepaid Rent Noncurrent PrepaidRentNoncurrent	1567000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84212000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79474000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9240000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7673000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	48842000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	29498000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5679000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3868000	USD
CY2022Q1	us-gaap	Assets Assets	983770000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	47626000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46464000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2627000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	8246000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8297000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	84629000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	82165000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7594000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7147000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2620000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2621000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	191740000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	166936000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10283000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10283000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3271000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64499000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	746352000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	730767000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21215000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24018000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	725138000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	706750000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	983770000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	233310000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6356000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6356000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	258632000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146958296	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	146958296	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	146402991	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146402991	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	940060000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	179410000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34168000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	430000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28787000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7409000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26910000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11870000	USD
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	176562000	USD
CY2021Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	49744000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2848000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14755000	USD
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-51000	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-535000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2803000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14257000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1226000	USD
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	65000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146526370	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18378777	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2803000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	13031000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153036804	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25904338	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	706750000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	270000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	720000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16035000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2803000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	725138000	USD
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	65000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-101400000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	32000	USD
CY2021Q1	hlth	Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions	46000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3021000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	13031000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-85270000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2803000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	13031000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10606000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4884000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16035000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3021000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1996000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	625000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	318000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-28759000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	9410000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44179000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14759000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1618000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1710000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	0	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-983000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1876000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1143000	USD
CY2022Q1	hlth	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	4073000	USD
CY2021Q1	hlth	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	2024000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18305000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13082000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-51000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	273000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2464000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-15989000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1002000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	28000	USD
CY2022Q1	hlth	Increase Decrease In Finance Lease Interest Expense IncreaseDecreaseInFinanceLeaseInterestExpense	51000	USD
CY2021Q1	hlth	Increase Decrease In Finance Lease Interest Expense IncreaseDecreaseInFinanceLeaseInterestExpense	49000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31521000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35113000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12782000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30491000	USD
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1273000	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1350000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14055000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31841000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	270000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	32000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	82250000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	720000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	781000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24478000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	696000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	382000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-873000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	56641000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16593000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10313000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423710000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129255000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	440303000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118942000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426465000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38942000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	13838000	USD
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	USD
CY2021Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	80000000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	440303000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118942000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	267000	USD
CY2022Q1	hlth	Early Exercised Stock Options Liability EarlyExercisedStockOptionsLiability	0	USD
CY2021Q1	hlth	Early Exercised Stock Options Liability EarlyExercisedStockOptionsLiability	46000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2611000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	18621000	USD
CY2022Q1	hlth	Prepaid Rent Reclassified To Right Of Use Assets PrepaidRentReclassifiedToRightOfUseAssets	50000	USD
CY2021Q1	hlth	Prepaid Rent Reclassified To Right Of Use Assets PrepaidRentReclassifiedToRightOfUseAssets	0	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9235000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8623000	USD
CY2022Q1	hlth	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	0	USD
CY2021Q1	hlth	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	547000	USD
CY2022Q1	hlth	Software Development Costs Incurred But Not Yet Paid SoftwareDevelopmentCostsIncurredButNotYetPaid	897000	USD
CY2021Q1	hlth	Software Development Costs Incurred But Not Yet Paid SoftwareDevelopmentCostsIncurredButNotYetPaid	0	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying unaudited interim condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to revenue recognition, net accounts receivable, equity-based compensation expense, product warranty reserve, the recoverability of its long-lived assets and net deferred tax assets (and related valuation allowance). The Company evaluates </span></div>its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	600000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1100000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	92448000	USD
CY2022Q1	hlth	Contract With Customer Liability Unearned Revenue From Cash Received During The Period ContractWithCustomerLiabilityUnearnedRevenueFromCashReceivedDuringThePeriod	2464000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	94912000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	500000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	USD
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	57223000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	46273000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	16014000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10920000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	60775000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	33863000	USD
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1445000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2668000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	132567000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	88388000	USD
CY2022Q1	hlth	Prepaid Expense Excluding Prepaid Inventory Current PrepaidExpenseExcludingPrepaidInventoryCurrent	28635000	USD
CY2021Q4	hlth	Prepaid Expense Excluding Prepaid Inventory Current PrepaidExpenseExcludingPrepaidInventoryCurrent	30153000	USD
CY2022Q1	hlth	Prepaid Inventory Current PrepaidInventoryCurrent	14267000	USD
CY2021Q4	hlth	Prepaid Inventory Current PrepaidInventoryCurrent	15736000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	42902000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45889000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	51672000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	41669000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	234422000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	219125000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	182750000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	177456000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	10000000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	4800000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9200000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9800000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2627000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	9741000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5638000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2671000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2067000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7070000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3571000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9240000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7673000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84212000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79474000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9182000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9821000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7594000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7147000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2620000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2621000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	47626000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46464000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3271000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2762000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1117000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	639000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	335000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	51000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	49000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	3452000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	1501000	USD
CY2022Q1	hlth	Accrued Liabilities Purchases Current AccruedLiabilitiesPurchasesCurrent	6882000	USD
CY2021Q4	hlth	Accrued Liabilities Purchases Current AccruedLiabilitiesPurchasesCurrent	285000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12165000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13693000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8535000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6371000	USD
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6992000	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4284000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	5235000	USD
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4865000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	39809000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	29498000	USD
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	297800000	USD
CY2021Q3	hlth	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	550000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9163160	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	294856	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	74964	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	11.77
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	14833	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	15.61
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8778507	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6151757	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.89
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8778507	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.22
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y6M
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2803000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	13031000	USD
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	11366000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2803000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1665000	USD
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	525000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2803000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2190000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146526370	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18378777	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153036804	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25904338	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12446972	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2926821	shares
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.086
CY2022Q1	hlth	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4865000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1211000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	841000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	5235000	USD
CY2021Q4	hlth	Number Of Letters Of Credit In Effect NumberOfLettersOfCreditInEffect	1	letter_of_credit
CY2021Q4	hlth	Number Of Letters Of Credit In Effect NumberOfLettersOfCreditInEffect	1	letter_of_credit
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	800000	USD

Files In Submission

Name	View Source	Status
0001628945-22-000052-index-headers.html	Edgar Link	pending
0001628945-22-000052-index.html	Edgar Link	pending
0001628945-22-000052.txt	Edgar Link	pending
0001628945-22-000052-xbrl.zip	Edgar Link	pending
exhibit31103312210-q.htm	Edgar Link	pending
exhibit31203312210-q.htm	Edgar Link	pending
exhibit32103312210-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hlth-20220331.htm	Edgar Link	pending
hlth-20220331.xsd	Edgar Link	pending
hlth-20220331_cal.xml	Edgar Link	unprocessable
hlth-20220331_def.xml	Edgar Link	unprocessable
hlth-20220331_htm.xml	Edgar Link	completed
hlth-20220331_lab.xml	Edgar Link	unprocessable
hlth-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLTHQ
Cue Health Inc. Stock $hlthq

2022 Q1 Form 10-Q Financial Statement

#000162894522000052 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLTHQ Cue Health Inc. Stock $hlthq

2022 Q1 Form 10-Q Financial Statement

#000162894522000052 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLTHQ
Cue Health Inc. Stock $hlthq